Concomitant with its ability to mediate T-cell killing of CRC tumor cells, preclinical data show that MGD007 induces expression of PD-1/PD-L1 on T cells and CRC tumor cell lines, respectively. This evidence concerns the gene PDCD1 and neoplasm.